Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2019-01-22

Clinical Trial Update: ATAREAL (Antihistamine Treatment for Allergic Rhinitis in Real Life) [Phase 4]

View source ↗

Summary

Phase 4 trial update for ATAREAL evaluating antihistamine treatment in allergic perennial rhinitis; study completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • AT-AREAL (Antihistamine)

Snippet

Sponsor: UCB S.A. - Pharma Sector | Conditions: Rhinitis, Allergic, Perennial | Phase 4 | Status: COMPLETED | Results posted: 2019-01-22